UA65702A - Composition for treating vaginosis of bacterial origin, method for its preparation, and method for treating vaginosis of bacterial origin - Google Patents
Composition for treating vaginosis of bacterial origin, method for its preparation, and method for treating vaginosis of bacterial origin Download PDFInfo
- Publication number
- UA65702A UA65702A UA2002129729A UA2002129729A UA65702A UA 65702 A UA65702 A UA 65702A UA 2002129729 A UA2002129729 A UA 2002129729A UA 2002129729 A UA2002129729 A UA 2002129729A UA 65702 A UA65702 A UA 65702A
- Authority
- UA
- Ukraine
- Prior art keywords
- drug
- mass
- acceptable
- bacteria
- preparation
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims description 24
- 230000001580 bacterial effect Effects 0.000 title abstract description 8
- 239000000203 mixture Substances 0.000 title abstract description 6
- 241000894006 Bacteria Species 0.000 claims abstract description 31
- 241000186660 Lactobacillus Species 0.000 claims abstract description 26
- 239000002594 sorbent Substances 0.000 claims abstract description 20
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 10
- 239000000654 additive Substances 0.000 claims abstract description 10
- 230000000996 additive effect Effects 0.000 claims abstract description 10
- 230000001681 protective effect Effects 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 77
- 229940079593 drug Drugs 0.000 claims description 75
- 230000000813 microbial effect Effects 0.000 claims description 28
- 208000004926 Bacterial Vaginosis Diseases 0.000 claims description 23
- 208000037009 Vaginitis bacterial Diseases 0.000 claims description 23
- 210000001215 vagina Anatomy 0.000 claims description 17
- 230000000694 effects Effects 0.000 claims description 10
- 239000004615 ingredient Substances 0.000 claims description 9
- 244000005700 microbiome Species 0.000 claims description 9
- 239000000829 suppository Substances 0.000 claims description 9
- 210000004400 mucous membrane Anatomy 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 6
- 230000000845 anti-microbial effect Effects 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- 230000000855 fungicidal effect Effects 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 230000000843 anti-fungal effect Effects 0.000 claims description 2
- 229940121375 antifungal agent Drugs 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 235000008216 herbs Nutrition 0.000 claims description 2
- 239000013589 supplement Substances 0.000 claims description 2
- 230000003100 immobilizing effect Effects 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 abstract description 4
- 238000004108 freeze drying Methods 0.000 abstract description 3
- 241000894007 species Species 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000035899 viability Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000002609 medium Substances 0.000 description 6
- 238000004321 preservation Methods 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 108010006741 lactobacterin Proteins 0.000 description 3
- 244000005706 microflora Species 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000003883 ointment base Substances 0.000 description 3
- 229910021647 smectite Inorganic materials 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010048461 Genital infection Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000000369 enteropathogenic effect Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 208000013464 vaginal disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002129729A UA65702A (en) | 2002-12-05 | 2002-12-05 | Composition for treating vaginosis of bacterial origin, method for its preparation, and method for treating vaginosis of bacterial origin |
| RU2002134006/15A RU2248212C2 (ru) | 2002-12-05 | 2002-12-18 | Препарат для лечения бактериального вагиноза, способ его получения и способ лечения бактериального вагиноза |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002129729A UA65702A (en) | 2002-12-05 | 2002-12-05 | Composition for treating vaginosis of bacterial origin, method for its preparation, and method for treating vaginosis of bacterial origin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA65702A true UA65702A (en) | 2004-04-15 |
Family
ID=34515111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2002129729A UA65702A (en) | 2002-12-05 | 2002-12-05 | Composition for treating vaginosis of bacterial origin, method for its preparation, and method for treating vaginosis of bacterial origin |
Country Status (2)
| Country | Link |
|---|---|
| RU (1) | RU2248212C2 (ru) |
| UA (1) | UA65702A (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2474417C2 (ru) * | 2007-06-18 | 2013-02-10 | Дольхаи Клиника Эгесшегюдьи Кфт. | Биоцидные капсулы, содержащий их препарат и тампон, содержащий препарат |
| RU2445988C1 (ru) * | 2010-12-29 | 2012-03-27 | Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО "НижГМА Росздрава") | Способ лечения хронических воспалительных заболеваний органов малого таза |
| CN109112155A (zh) * | 2018-08-02 | 2019-01-01 | 南昌大学 | 乳酸乳球菌mg1363的构建及其在治疗细菌性阴道炎中的应用 |
-
2002
- 2002-12-05 UA UA2002129729A patent/UA65702A/uk unknown
- 2002-12-18 RU RU2002134006/15A patent/RU2248212C2/ru active IP Right Revival
Also Published As
| Publication number | Publication date |
|---|---|
| RU2248212C2 (ru) | 2005-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4314995A (en) | Pharmaceutical lactobacillus preparations | |
| US10195239B2 (en) | Extract of Trigonella foenum-graecum | |
| CN109010825B (zh) | 一种阴道原位凝胶制剂及其制备方法和应用 | |
| RU2536264C2 (ru) | Композиция для наружного применения на коже, содержащая соль и сахар в качестве активных ингредиентов, для предотвращения и лечения вагиноза, и ее применение | |
| US20120245132A1 (en) | Composition Comprising Benzoic Acid in Combination with Organic Acid Preservatives as Active Ingredients and the Use Thereof | |
| RU2291694C2 (ru) | Фармацевтическая композиция, содержащая фунгицид, бактериостатический сульфонамид и антибактериальное соединение для местного применения | |
| RU2031586C1 (ru) | Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения | |
| US20190167734A1 (en) | Pharmaceutical composition and methods for the prevention and/or treatment of Staphylococcus aureus using artificial bacterial colonization | |
| CN113995744B (zh) | 一种组合物及其抗菌应用 | |
| EP0363491B1 (fr) | Preparation bacterienne pour prophylaxie et traitement de processus inflammatoires et d'affections allergiques | |
| CN108404111A (zh) | 一种以芸豆植物凝集素为主要成分的抑菌抗病毒制剂 | |
| UA65702A (en) | Composition for treating vaginosis of bacterial origin, method for its preparation, and method for treating vaginosis of bacterial origin | |
| CN111905058A (zh) | 一种用于皮肤黏膜护理和伤口修复的药物组合物及其制备方法 | |
| RU2354392C1 (ru) | Средство для лечения бактериального вагиноза и способ лечения бактериального вагиноза | |
| RU2367454C1 (ru) | Средство интимной гигиены "фемивит" | |
| CA1227427A (en) | Therapeutic agent for the use in cancer treatment | |
| GB1585863A (en) | Pharmaceutical lactobacillus preparations | |
| KR20220154142A (ko) | 생물막 형성 방해 및 생물막 관련 질환 치료용 조성물 | |
| RU2323735C1 (ru) | Средство для лечения и профилактики заболеваний человека, передающихся половым путем, и способ его получения | |
| WO2008035370A2 (en) | Compositions for prevention and treatment of mastitis and metritis | |
| CN1462584A (zh) | 外用消毒剂 | |
| RU2745236C1 (ru) | Способ лечения и профилактики субклинического мастита у коров | |
| CN111658763B (zh) | 一种用于妇科的抑菌凝胶及其制备方法 | |
| CN106974926B (zh) | 一种用于治疗压疮的药物组合物及其制备方法和用途 | |
| RU2002134006A (ru) | Препарат для лечения бактериального вагиноза, способ его получения и способ лечения бактериального вагиноза |